1.
Keen R, Pantin J, Savage N, Dainer PM. Treatment of refractory anemia with ring sideroblasts associated with marked thrombocytosis with lenalidomide in a patient testing negative for 5q deletion and JAK2 V617F and MPL W515K/L mutations. Hematol Rep [Internet]. 2016Nov.2 [cited 2020Sep.22];8(4). Available from: https://www.pagepress.org/journals/index.php/hr/article/view/6592